Phospho-Trin 250 Neutral Interactions
There are 71 drugs known to interact with Phospho-Trin 250 Neutral (potassium phosphate/sodium phosphate), along with 9 disease interactions. Of the total drug interactions, 28 are major, 28 are moderate, and 15 are minor.
- View all 71 medications that may interact with Phospho-Trin 250 Neutral
- View Phospho-Trin 250 Neutral disease interactions (9)
Most frequently checked interactions
View interaction reports for Phospho-Trin 250 Neutral (potassium phosphate / sodium phosphate) and the medicines listed below.
- acetaminophen
- albuterol
- alpha-lipoic acid
- Aspir 81 (aspirin)
- atorvastatin
- bacitracin topical
- belatacept
- Cardura (doxazosin)
- carvedilol
- chlorpheniramine
- cinnamon
- Ciprodex (ciprofloxacin / dexamethasone otic)
- ciprofloxacin ophthalmic
- clonazepam
- cranberry
- diazepam
- enalapril
- Farxiga (dapagliflozin)
- furosemide
- gabapentin
- gentamicin
- Humalog KwikPen (insulin lispro)
- irbesartan
- magnesium oxide
- Myfortic (mycophenolic acid)
- pantoprazole
- Pristiq (desvenlafaxine)
- tamsulosin
- Tresiba (insulin degludec)
- Tums Extra Strength 750 (calcium carbonate)
Phospho-Trin 250 Neutral disease interactions
There are 9 disease interactions with Phospho-Trin 250 Neutral (potassium phosphate / sodium phosphate) which include:
- sodium/water balance
- inflammatory bowel disease
- intestinal obstruction disorders
- hypocalcemia
- phosphate imbalance
- electrolyte imbalance
- aluminum toxicity/renal impairment
- cardiac disease
- hypomagnesemia
More about Phospho-Trin 250 Neutral (potassium phosphate / sodium phosphate)
- Phospho-Trin 250 Neutral consumer information
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.